Field Medical’s FieldForce™ Ablation System Earns FDA TAP Pilot Acceptance and Breakthrough Device Designation for the Treatment of Ventricular Tachycardia.
First and only contact force pulsed field ablation (PFA) system engineered to revolutionize care for the hundreds of thousands at risk of death from ventricular tachycardia (VT). FDA's TAP Pilot and Breakthrough Device Designation are awarded to medical devices that could provide more effective treatment compared to existing approved treatments,...
LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System
Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings Replaces time-consuming manual spot checking with continuous, near real-time active patient monitoring Web-based system displays multiple patient physiological data continuously, with visual alarms and alert notifications for streamlined patient care Developed to support...
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
EAST RUTHERFORD, N.J., Dec. 5, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has signed an agreement with Eli Lilly and Company (Lilly) to deliver accelerated access to clinical development capabilities for Lilly's biotech collaborators. Through this agreement, Cambrex will partner with Lilly Catalyze360-ExploR&D,...
NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis
MILAN, Dec. 5, 2024 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical company headquartered in Italy, presents positive results from Phase II MIRAKLE study, a multicentre, randomized, blinded-assessor, phase II non-inferiority study evaluating the efficacy and tolerability of NTC014 (quinolone antibiotic + NSAID in eye drops solution) in the treatment of bacterial...
Cao Thang International Eye Hospital – Marking a footprint on the map of global ophthalmology
HO CHI MINH CITY, Vietnam, Dec. 5, 2024 /PRNewswire/ -- On November 10, 2024, Cao Thang International Eye Hospital was proudly certified to be an official membership with the World Association of Eye Hospitals (WAEH) at the 18th annual meeting which was held in China. Cao Thang International Eye Hospital is well-known as the first and only eye hospital to achieve Joint...
SIMPLY HEALTH Appoints Aaron Kwok as Brand Ambassador for Active Probiotic Products
HONG KONG, Dec. 5, 2024 /PRNewswire/ -- SIMPLY HEALTH, a leading health supplement brand in Hong Kong, is excited to announce the appointment of renowned singer and actor Aaron Kwok as the brand ambassador for its "Active Probiotics" line. The announcement was made during a press conference held at the W Hotel, showcasing Kwok's commitment to health and wellness....
Daewoong Pharmaceutical Captivates Global Experts at AMWC-SEA with ‘Nabolift,’ Redefining Toxin Treatments
- At "AMWC SEA 2024," one of the world's top three aesthetic medicine congresses, the Nabota booth attracted over 500 visitors. - Educated over 300 Thai physicians on the innovative "Nabolift" technique through the "Nabota Master Class (NMC)." - Established its position as a premium global brand with proven "efficacy" and "quality."...
XREAL New AR Glasses Receive TÜV Rheinland Eye Comfort (5 Star) and High Visibility Certificates
SHANGHAI, Dec. 5, 2024 /PRNewswire/ -- TÜV Rheinland Greater China, an international independent third-party testing, inspection, and certification organization, has issued Eye Comfort (5 Star), High Visibility, Color Accuracy, Low Blue Light, and Flicker Free certifications to the newest augmented reality (AR) glasses created by XREAL, the XREAL One Series. These achievements mark a groundbreaking advancement in AR eyewear, setting new benchmarks for user...
MINISH Expands into Japan: Gaining Recognition as an Alternative to Orthodontic Treatment
TOKYO and SEOUL, South Korea, Dec. 5, 2024 /PRNewswire/ -- Japanese dentists who attended the Global MINISH Academy have announced plans to adopt MINISH. This shows the potential for the expansion of MINISH Members Clinics (MMCs) in Japan. There are currently 40 MMCs worldwide, with 38 in South Korea, one in Shinjuku, Tokyo, and one in Vancouver, Canada. ...
CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial
MELBOURNE, Australia, Dec. 5, 2024 /PRNewswire/ -- Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, has successfully completed its Phase 1 clinical trial of CYP-006TK in diabetic foot ulcers (DFU). Key Highlights The trial met its primary objective, with CYP-006TK found to be safe and well-tolerated – no participants...
